Literature DB >> 8878055

Adenosine A2A receptors mediate the inhibitory effect of adenosine on formyl-Met-Leu-Phe-stimulated respiratory burst in neutrophil leucocytes.

B B Fredholm1, Y Zhang, I van der Ploeg.   

Abstract

Using the reverse transcription polymerase chain reaction (RT-PCR) we found that human neutrophils express mRNA for both A2A and A2B adenosine receptors, and using selective adenosine receptor agonists and antagonists we have characterized the type of adenosine receptor mediating inhibition of formyl-Met-Leu-Phe (fMLP)-induced oxidative burst. The order of potency of agonists was 5'-N-ethyl-carboxamidoadenosine (NECA) > 2-phenylaminoadenosine > 2-[p-(2-carbonyl-ethyl)-phenyl-ethylamino]-5'-N-ethyl-carboxamido adenosine (CGS 21680) > adenosine > N6-cyclopentyl-adenosine. This agrees with the agonist potency at human A2A receptors. The effect of adenosine was antagonized by 30 microM theophylline > caffeine = paraxanthine, i.e. concentrations close to those occurring in plasma after consumption of caffeine-containing beverages. The effect of NECA was unaltered by the A1 receptor antagonist 1,3-dipropyl-8-cyclopentylxanthine, but inhibited by the A2A receptor selective antagonists 4-amino-8-chloro-1-phenyl-[1,2,4]-triazolo[4,3-a]quinoxaline (CP 66,713), 1,3-dipropyl-8-(3,4-dimethoxystyryl) -7-methylxanthine (KF 17387) and 8-(3-chlorostyryl)caffeine as well as by the non-selective, non-xanthine antagonist 5-amino-9-chloro-2-(2-furyl)-[1,2,4]-triazolo-[1,5-c]quinazoline methane sulphonate (CGS 15943). The adenosine receptor mediated responses were antagonized by the protein kinase A blocker Rp-cyclic adenosine 3',5'-phosphorothioate (Rp-cAMP). In conclusion, the adenosine-induced inhibition of neutrophil activation is mediated by adenosine A2A receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8878055     DOI: 10.1007/bf00171056

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  38 in total

Review 1.  Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke.

Authors:  P M Kochanek; J M Hallenbeck
Journal:  Stroke       Date:  1992-09       Impact factor: 7.914

2.  Molecular cloning and expression of an adenosine A2b receptor from human brain.

Authors:  K D Pierce; T J Furlong; L A Selbie; J Shine
Journal:  Biochem Biophys Res Commun       Date:  1992-08-31       Impact factor: 3.575

3.  Occupancy of G alpha s-linked receptors uncouples chemoattractant receptors from their stimulus-transduction mechanisms in the neutrophil.

Authors:  B N Cronstein; K A Haines; S Kolasinski; J Reibman
Journal:  Blood       Date:  1992-08-15       Impact factor: 22.113

4.  The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.

Authors:  B N Cronstein; D Naime; E Ostad
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

5.  Adenosine inhibits fMLP-stimulated adherence and superoxide anion generation by human neutrophils at an early step in signal transduction.

Authors:  T H Burkey; R O Webster
Journal:  Biochim Biophys Acta       Date:  1993-02-17

6.  Chemiluminescence detection of H2O2 produced by human neutrophils during the respiratory burst.

Authors:  M P Wymann; V von Tscharner; D A Deranleau; M Baggiolini
Journal:  Anal Biochem       Date:  1987-09       Impact factor: 3.365

7.  Myocardial protective effects of adenosine. Infarct size reduction with pretreatment and continued receptor stimulation during ischemia.

Authors:  C F Toombs; S McGee; W E Johnston; J Vinten-Johansen
Journal:  Circulation       Date:  1992-09       Impact factor: 29.690

Review 8.  Neuroprotective role of adenosine in cerebral ischaemia.

Authors:  K A Rudolphi; P Schubert; F E Parkinson; B B Fredholm
Journal:  Trends Pharmacol Sci       Date:  1992-12       Impact factor: 14.819

9.  Inhibition of neutrophil function in vitro by nimesulide. Preliminary evidence of an adenosine-mediated mechanism.

Authors:  P L Capecchi; L Ceccatelli; U Beermann; F Laghi Pasini; T Di Perri
Journal:  Arzneimittelforschung       Date:  1993-09

10.  Methylxanthine bronchodilators potentiate multiple human neutrophil functions.

Authors:  C J Schmeichel; L L Thomas
Journal:  J Immunol       Date:  1987-03-15       Impact factor: 5.422

View more
  25 in total

Review 1.  A(2A) adenosine receptors in human peripheral blood cells.

Authors:  S Gessi; K Varani; S Merighi; E Ongini; P A Borea
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

2.  Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists.

Authors:  G W Sullivan; J M Rieger; W M Scheld; T L Macdonald; J Linden
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

3.  Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells.

Authors:  S Gessi; K Varani; S Merighi; A Morelli; D Ferrari; E Leung; P G Baraldi; G Spalluto; P A Borea
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

Review 4.  Adenosine receptors and asthma.

Authors:  R A Brown; D Spina; C P Page
Journal:  Br J Pharmacol       Date:  2008-03       Impact factor: 8.739

Review 5.  Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.

Authors:  Xiaolun Huang; Daniel J Moore; Robert J Ketchum; Craig S Nunemaker; Boris Kovatchev; Anthony L McCall; Kenneth L Brayman
Journal:  Endocr Rev       Date:  2008-07-29       Impact factor: 19.871

Review 6.  Regulation of neutrophil function by adenosine.

Authors:  Kathryn E Barletta; Klaus Ley; Borna Mehrad
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-04       Impact factor: 8.311

7.  The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation.

Authors:  Preeti Chhabra; Joel Linden; Peter Lobo; Mark Douglas Okusa; Kenneth Lewis Brayman
Journal:  Curr Diabetes Rev       Date:  2012-11

8.  Adenosine A₂A agonist improves lung function during ex vivo lung perfusion.

Authors:  Abbas Emaminia; Damien J Lapar; Yunge Zhao; John F Steidle; David A Harris; Victor E Laubach; Joel Linden; Irving L Kron; Christine L Lau
Journal:  Ann Thorac Surg       Date:  2011-10-31       Impact factor: 4.330

Review 9.  Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases.

Authors:  Bruce N Cronstein; Michail Sitkovsky
Journal:  Nat Rev Rheumatol       Date:  2016-11-10       Impact factor: 20.543

10.  The role of adenosine A2A receptor signaling in bronchiolitis obliterans.

Authors:  Christine L Lau; Yunge Zhao; Irving L Kron; Mark H Stoler; Victor E Laubach; Gorav Ailawadi; Joel Linden
Journal:  Ann Thorac Surg       Date:  2009-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.